Overview
Innovating healthcare through technology and tools for industry change.
Founded
2018
Deals ยท 12mo
5
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
OmicsBank | Aug 2026Led | $2 MSeed | |
Anomaly | May 2026Participated | $17 MOther Equity | |
Gravity Rail | Apr 2026Led | $3 MSeed | |
Worki | Apr 2026Led | $3 MSeed | |
Thrivory | Nov 2025Led | $29 MDebt | |
Nuxera AI | Oct 2025Participated | $3 MSeed | |
Translucent AI | Aug 2025Participated | $7 MSeed | |
Vitalic | Dec 2024Participated | $4 MSeed | |
Kins | Jul 2024Participated | $7 MSeries A | |
Helpful | Jul 2023Led | $8 MSeed | |
Intrinsic | May 2023Participated | $15 MOther Equity | |
Kins | Jun 2022Participated | $4 MSeed | |
OmicsBank | Aug 2026Led | $2 MSeed | |
Anomaly | May 2026Participated | $17 MOther Equity | |
Gravity Rail | Apr 2026Led | $3 MSeed | |
Worki | Apr 2026Led | $3 MSeed | |
Thrivory | Nov 2025Led | $29 MDebt | |
Nuxera AI | Oct 2025Participated | $3 MSeed | |
Translucent AI | Aug 2025Participated | $7 MSeed | |
Vitalic | Dec 2024Participated | $4 MSeed | |
Kins | Jul 2024Participated | $7 MSeries A | |
Helpful | Jul 2023Led | $8 MSeed | |
Intrinsic | May 2023Participated | $15 MOther Equity | |
Kins | Jun 2022Participated | $4 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 6 | 4 |
| Series A | 0 | 6 |
| Series B | 0 | 3 |
| Series C+ | 0 | 1 |
| Other Equity | 0 | 3 |
| Debt | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '19 | 1 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 1 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 2 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 1 |
| Oct '21 | 1 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 2 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 2 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 23 |
| Consumer & Lifestyle | 7 |
| Fintech | 5 |
| AI & Machine Learning | 3 |
| Marketing & Advertising | 1 |
| E-Commerce & Retail | 1 |
| Professional Services | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 6 |
| $5M-$10M | 5 |
| $10M-$25M | 5 |
| $25M-$50M | 5 |
| $50M-$100M | 2 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 22 |
| Saudi Arabia | 1 |
| India | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Declaration Partners | 5 |
| Tiger Global | 4 |
| 7wireVentures | 3 |
| ACME Capital | 3 |
| Forerunner Ventures | 3 |
| Link Ventures | 3 |
| W Health Ventures | 3 |
| Addition | 2 |
| Define Ventures | 2 |
| Fifth Wall | 2 |
| RRE Ventures | 2 |
| Threshold Ventures | 2 |
| Alumni Ventures | 1 |
| Asahi Kasei Ventures | 1 |
| AV8 Ventures | 1 |
| CommonSpirit Health | 1 |
| FCA Venture Partners | 1 |
| Founders Fund | 1 |
| FPV Ventures | 1 |
| Gaingels | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 7 | 29% |
| Participating | 17 | 71% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 4 | 57% |
| Co-led | 3 | 43% |
Team
Head of Strategic Partnerships
Head of Strategic Partnerships
Chief Executive Officer
OpCo Founding Chief of Staff
Director of New Ventures
Head of New Ventures
CEO & Co-Founder of a Stealth Venture
Venture Chair
President and COO
Strategy & Finance
Chief Executive Officer and Co-Founder of a Stealth Venture
CEO and Co-Founder at Stealth Venture with Redesign Health